IMGT Co.,Ltd. (XKON:456570)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,060
-230 (-2.04%)
At close: Aug 1, 2025
-2.04%
Market Cap56.70B
Revenue (ttm)102.33M
Net Income (ttm)731.32M
Shares Out5.13M
EPS (ttm)812.00
PE Ratio13.62
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,705
Average Volume831
Open10,750
Previous Close11,290
Day's Range10,560 - 11,290
52-Week Range6,970 - 17,810
Beta1.18
RSI51.14
Earnings Daten/a

About IMGT Co.,Ltd.

IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems. It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation t... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 456570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.